Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × cabazitaxel × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2 Thoracic 1 Head & Neck 1 Gynecologic 1 CNS 1 Breast 1

Conditions

Ovarian Neoplasms 2 Recurrence 1

Interventions

Paclitaxel 17 Carboplatin 17 Cisplatin 9 Cyclophosphamide 7 Bevacizumab 6 Topotecan 5 Gemcitabine 5 pembrolizumab 4 olaparib 4 Letrozole 4 Interleukin-2 4 Doxorubicin 4 liposomal doxorubicin 3 fludarabine 3 chiauranib 3 camrelizumab 3 Injections 3 Hyperthermic Intraperitoneal Chemotherapy 3 Everolimus 3 Drug Therapy 3 Albumin-Bound Paclitaxel 3 rucaparib 2 pazopanib 2 iniparib 2 eprenetapopt 2 durvalumab 2 cemiplimab 2 avelumab 2 apatinib 2 aldesleukin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02560337 2020-10-08

CaTo-ROC

Vejle Hospital

Phase 2 Completed

Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡